Once in a while I find something interesting in my InvestorPlace newsletter, this time an new look at an old stock that I did well with: Novartis. I would have been delighted if I had thought of this at the beginning of the month, but it may still have some room after a pull back to go up again. Setting my sights at $46 today.
One downside to this stock is the foreign income tax, which can be hard to remember to factor into future earnings when planning buys and sells.Cheap, Lazy Reference links: Yahoo! Finance, Wall Street Survivor, Motley Fool CAPS, TheStreet, Google Finance, MSN Money